Search Orphan Drug Designations and Approvals
-
Generic Name: | Chlorhexidine gluconate mouthrinse |
---|---|
Date Designated: | 08/18/1986 |
Orphan Designation: | For use in the amelioration of oral mucositis associated with cytoreductive therapy used in conditioning patients for bone marrow transplantation therapy. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Procter & Gamble Company Sharon Wood Technical Center 11370 Reed Hartman Highway Cincinnati, Ohio 45241 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-